The Patent Finder

Mateon Therapeutics, Inc.

Also on record
Records under this name other than the patents Mateon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Mateon Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,419,934Use of VDAS to enhance immunomodulating therapies against tumors
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,873,668Compositions and methods for inhibition of cathepsins
Lapsed on the fee record
Ended Jan 23, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 23, 2026USPTO record
US 7,456,214Chromene-containing compounds with anti-tubulin and vascular targeting activity
Term ended
Term ended Jan 30, 2025 · USPTO record
Term endedTerm ended Jan 30, 2025USPTO record
US 7,358,236Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents
Term ended
Term ended Nov 19, 2024 · USPTO record
Term endedTerm ended Nov 19, 2024USPTO record
US 8,198,302Compositions and methods with enhanced therapeutic activity
Lapsed on the fee record
Ended Jun 12, 2024 · USPTO record
Lapsed on the fee recordEnded Jun 12, 2024USPTO record
US 9,040,500Method for treating hematopoietic neoplasms
Lapsed on the fee record
Ended May 26, 2023 · USPTO record
Lapsed on the fee recordEnded May 26, 2023USPTO record
US 6,773,702Use of Combretastatin A4 and Its Prodrugs as an Immune Enhancing Therapy
Term ended
Term ended Dec 26, 2021 · High confidence
Term endedTerm ended Dec 26, 2021High confidence
US 7,037,906Methods for Modulating Tumor Growth and Metastasis
Term ended
Term ended Dec 20, 2021 · High confidence
Term endedTerm ended Dec 20, 2021High confidence
US 6,593,374Tubulin binding ligands and corresponding prodrug constructs
Term ended
Term ended Jul 27, 2021 · USPTO record
Term endedTerm ended Jul 27, 2021USPTO record
US 6,743,937Efficient method of synthesizing combretastatin A-4 prodrugs
Term ended
Term ended Jul 17, 2021 · USPTO record
Term endedTerm ended Jul 17, 2021USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited